Sequenom Provides Further Details on T21 Test Timeline | GenomeWeb

By Edward Winnick

NEW YORK (GenomeWeb News) – A Sequenom official yesterday provided an update on the firm's timeline for commercialization of its highly anticipated trisomy 21 non-invasive, pre-natal test.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.